Natco Pharma begins sales of Bristol Myers’ cancer drug Dasatinib – Economic Times

July 12, 2012 Posted By: Leave a comment
"The regulator's only job is to look at safety and efficacy of drugs, and it is not obliged to look at validity of patents," said Shamnad Basheer, professor in Intellectual Property Law, National University of Judicial Sciences.
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>